0001140361-23-060180.txt : 20231229 0001140361-23-060180.hdr.sgml : 20231229 20231229160120 ACCESSION NUMBER: 0001140361-23-060180 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231229 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STRATA Skin Sciences, Inc. CENTRAL INDEX KEY: 0001051514 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133986004 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51481 FILM NUMBER: 231527602 BUSINESS ADDRESS: STREET 1: 5 WALNUT GROVE DRIVE STREET 2: SUITE 140 CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 215-619-3200 MAIL ADDRESS: STREET 1: 5 WALNUT GROVE DRIVE STREET 2: SUITE 140 CITY: HORSHAM STATE: PA ZIP: 19044 FORMER COMPANY: FORMER CONFORMED NAME: MELA SCIENCES, INC. /NY DATE OF NAME CHANGE: 20100504 FORMER COMPANY: FORMER CONFORMED NAME: ELECTRO OPTICAL SCIENCES INC /NY DATE OF NAME CHANGE: 19971216 8-K 1 ef20017695_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): December 29, 2023

graphic

STRATA SKIN SCIENCES, INC.
(Exact Name of Registrant Specified in Charter)

 Delaware
000-51481
13-3986004
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

5 Walnut Grove Drive, Suite 140, Horsham, Pennsylvania
  
     19044
(Address of Principal Executive Offices)
  
(Zip Code)

Registrant's telephone number, including area code:   215-619-3200

 (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value per share
SSKN
The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01
Regulation FD Disclosure

On December 29, 2023  STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, issued a press release announcing   that it had renewed its services  agreement with Cutech, Inc. (the parent company of Kosmo Meditech) for a combination of direct recurring revenue sales and direct capital sales and in Korea. A copy of the press release is filed herewith as Exhibit 99.1.

The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10 of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of any such information.

Item 8.01
Other Events.

Effective January 1, 2024, the CPT® Editorial Panel of the American Medical Association which is responsible for maintaining CPT codes, has revised CPT codes 96920-96922.  Prior to the change, the codes were described as “Laser treatment for inflammatory skin diseases (psoriasis)”. Each of the codes defines the reimbursement for treatments of different skin surface areas.  Post change, the codes are described as “Excimer laser treatment for psoriasis”.  The Company’s flagship product, XTRAC, as well as the Pharos technology acquired by the Company in 2021 (no longer marketed)  are the only excimer laser devices currently marketed in the United States that meet the requirements of the revised description. These changes directly impact patients covered by Medicare and may impact others as private insurers decide to implement or reject the changes.

Safe Harbor Statement
The information in this filing includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to the Company’s plans, objectives, expectations and intentions and may contain words such as “will,” “may,” “seeks,” and “expects,” that suggest future events or trends. These statements, the Company’s ability to generate the growth in its core business, develop and grow an international recurring business model, the Company’s ability to develop social media marketing campaigns, and the Company’s ability to build a leading franchise in dermatology, are based on the Company’s current expectations and are inherently subject to significant uncertainties and changes in circumstances. Actual results may differ materially from the Company’s expectations due to financial, economic, business, competitive, market, regulatory, adverse market conditions or supply chain interruptions resulting from the corona virus and political factors or conditions affecting the Company and the medical device industry in general, as well as more specific risks and uncertainties set forth in the Company’s SEC reports on Forms 10-Q and 10-K. Given such uncertainties, any or all these forward-looking statements may prove to be incorrect or unreliable. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release. The Company urges investors to carefully review its SEC disclosures available at www.sec.gov and www.strataskinsciences.com.

Item 9.01
Financial Statements and Exhibits

(d) Exhibits

99.1 Strata Skin Sciences Press Release Dated December 28, 2023

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
STRATA SKIN SCIENCES, INC.
Dated: December 29, 2023


By: /s/ Christopher Lesovitz


Christopher Lesovitz


Chief Financial Officer


EX-99.1 2 ef20017695_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1
 
STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech
 
Agreement further solidifies the strength and growth of the partnership between STRATA Skin Sciences and Kosmo Meditech

HORSHAM, Pa., Dec. 29, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the expansion of a direct distribution agreement with Kosmo Meditech (“Kosmo”), which is now assigned to Kosmo's corporate parent, Cutech, Inc., effective as of January 1, 2024, for a combination of direct capital sales and direct recurring revenue sales in Korea.

The key highlights of this amendment, which reinforce STRATA's commitment to innovation and customer satisfaction, include:


 ●
Extended term through December 31, 2026, ensuring a prolonged and stable partnership


●
Established defined annual and quarterly performance-based purchase requirements, including STRATA becoming sole provider of gas and consumables, securing a consistent demand for STRATA’s products, providing a reliable forecast for production and inventory management, and ensuring stronger top-line revenue

“This agreement not only signifies the strength and growth of the partnership between STRATA and Kosmo but also reinforces STRATA's dedication to upholding the highest standards in product and service offerings for dermatological treatments worldwide,” stated Dr. Dolev Rafaeli, President and Chief Executive Officer of STRATA. “Korea continues to present a significant opportunity for us, leveraging Kosmo’s extensive in-country distribution network. This ongoing collaboration allows us to provide our customers with innovative therapeutic solutions while ensuring a framework for sustainable growth and market leadership.”

About Kosmo Meditech

Kosmo Meditech is a Korean distributor of medical devices in Dermatology and other medical markets. Kosmo Meditech has been a distributor of the XTRAC® excimer laser in partnership with STRATA Skin Sciences (and its predecessor) for over 16 years. The Kosmo platform in combination with the know-how generated by STRATA in the US will enable an efficient deployment of the business model into existing and new Dermatology clinics.

The Korean Dermatology clinic market comprises 1,800 physicians. XTRAC has been sold and is used by over 250 hospital and private practice clinics.

Korea’s Vitiligo and Psoriasis patient population is approximately 1 million. The treatment by 308nm Excimer is covered by the national health insurance with reimbursement rates of $15 to $50 per procedure.

About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System.

STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.

Safe Harbor

This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to the Company’s plans, objectives, expectations and intentions and may contain words such as “will,” “may,” “seeks,” and “expects,” that suggest future events or trends. These statements, the Company’s ability to launch and sell an acne treatment device and to integrate that device into its product offerings, the Company’s ability to develop, launch and sell products recently acquired or to be developed in the future, the Company’s ability to develop social media marketing campaigns, direct to dermatologist marketing campaigns, and the Company’s ability to build a leading franchise in dermatology and aesthetics, are based on the Company’s current expectations and are inherently subject to significant uncertainties and changes in circumstances. Actual results may differ materially from the Company’s expectations due to financial, economic, business, competitive, market, regulatory, adverse market conditions labor supply shortages, or supply chain interruptions resulting from the coronavirus, fiscal, and political factors, responses, or conditions affecting the Company, the medical device industry and our customers and patients in general, as well as more specific risks and uncertainties set forth in the Company’s SEC reports on Forms 10-Q and 10-K. Given such uncertainties, any or all these forward-looking statements may prove to be incorrect or unreliable. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release. The Company urges investors to carefully review its SEC disclosures available at www.sec.gov and www.strataskinsciences.com.

Investor Contact:
Rich Cockrell
CG Capital
Phone: +1 (404) 736-3838
sskn@cg.capital


 EX-101.SCH 3 sskn-20231229.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 sskn-20231229_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 sskn-20231229_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 logo.jpg begin 644 logo.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document and Entity Information
Dec. 29, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 29, 2023
Entity File Number 000-51481
Entity Registrant Name STRATA SKIN SCIENCES, INC.
Entity Central Index Key 0001051514
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 13-3986004
Entity Address, Address Line One 5 Walnut Grove Drive
Entity Address, Address Line Two Suite 140
Entity Address, City or Town Horsham
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19044
City Area Code 215
Local Phone Number 619-3200
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol SSKN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 8 ef20017695_8k_htm.xml IDEA: XBRL DOCUMENT 0001051514 2023-12-29 2023-12-29 false 0001051514 8-K 2023-12-29 STRATA SKIN SCIENCES, INC. DE 000-51481 13-3986004 5 Walnut Grove Drive Suite 140 Horsham PA 19044 215 619-3200 false false false false Common Stock, $0.001 par value per share SSKN NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 23 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://strataskinsciences.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ef20017695_8k.htm sskn-20231229.xsd sskn-20231229_lab.xml sskn-20231229_pre.xml logo.jpg http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ef20017695_8k.htm": { "nsprefix": "sskn", "nsuri": "http://strataskinsciences.com/20231229", "dts": { "inline": { "local": [ "ef20017695_8k.htm" ] }, "schema": { "local": [ "sskn-20231229.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "labelLink": { "local": [ "sskn-20231229_lab.xml" ] }, "presentationLink": { "local": [ "sskn-20231229_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://strataskinsciences.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20231229to20231229", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20017695_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231229to20231229", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20017695_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001140361-23-060180-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-23-060180-xbrl.zip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�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end